Evidence map›Paper›PMID 38627562›Full record

ArticleNature medicine2024

Placental IGFBP1 levels during early pregnancy and the risk of insulin resistance and gestational diabetes.

Marie-France Hivert, Frédérique White, Catherine Allard, Kaitlyn James, Sana Majid, François Aguet, Kristin G Ardlie, Jose C Florez, Andrea G Edlow, Luigi Bouchard and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
25.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The Double-Edged Sword of Gestational Insulin Resistance: Navigating Maternal Adaptation and Its Risks for Pregnancy and Offspring Health.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review
  9. LASSO regression-derived first-trimester (9-14Archives of gynecology and obstetrics · 2026
    Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Marie-France HivertDepartment of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA, USA. MHIVERT@mgb.org.ORCID 0000-0001-7752-2585
Frédérique WhiteDépartement de Biologie, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
Catherine AllardCentre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CRCHUS), Sherbrooke, Quebec, Canada.ORCID 0000-0002-8829-4984
Kaitlyn JamesDepartment of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Sana MajidDepartment of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA, USA.
François AguetBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Kristin G ArdlieBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Jose C FlorezDiabetes Unit, Endocrine Division, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-1730-9325
Andrea G EdlowDepartment of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-2915-5949
Luigi BouchardCentre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CRCHUS), Sherbrooke, Quebec, Canada.
Pierre-Étienne JacquesCentre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CRCHUS), Sherbrooke, Quebec, Canada.
S Ananth KarumanchiDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.ORCID 0000-0002-2281-6831
Camille E PoweDiabetes Unit, Endocrine Division, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Broad Institute · USHarvard University · USUniversité de Sherbrooke · CACedars-Sinai Medical Center · USCentre Hospitalier Universitaire de Sherbrooke · CA

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
Harvard Clinical and Translational Science Center (UL1)UL1TR000170 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2012 to 2013
$31.4M
Impact of insulin-like growth factors and binding proteins on gestational diabetes and fetal growthR01HD094150 · NICHD · HARVARD PILGRIM HEALTH CARE, INC. · PI Marie-France Hivert, Camille Elise Powe · 2018 to 2026
$4.2M
Elucidating Determinants of Gestational Beta-Cell Adaptation and FailureK23DK113218 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI POWE, CAMILLE ELISE · 2017 to 2021
$1.0M
Mentoring Investigators on the Clinical Translation of Cardiometabolic Genetic DiscoveriesK24HL157960 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI FLOREZ, JOSE CARLOS · 2021 to 2025
$626k
American Diabetes Association (ADA) #1-15-ACE-26 (to MFH)Fonds de Recherche du Québec - Santé (Fonds de la recherche en sante du Quebec) #20697Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) #MOP 115071Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) #PJT-152989NCATS NIH HHS UL1 TR000170NCATS NIH HHS UL1 TR001102NHLBI NIH HHS K24 HL157960NICHD NIH HHS R01 HD094150NIDDK NIH HHS K23 DK113218U.S. Department of Health & Human Services | National Institutes of Health (NIH) K23DK113218U.S. Department of Health & Human Services | National Institutes of Health (NIH) NHLBI K24 HL157960U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01HD094150
6 · The paper itself

Abstract

Reduced insulin sensitivity (insulin resistance) is a hallmark of normal physiology in late pregnancy and also underlies gestational diabetes mellitus (GDM). We conducted transcriptomic profiling of 434 human placentas and identified a positive association between insulin-like growth factor binding protein 1 gene (IGFBP1) expression in the placenta and insulin sensitivity at ~26 weeks gestation. Circulating IGFBP1 protein levels rose over the course of pregnancy and declined postpartum, which, together with high gene expression levels in our placenta samples, suggests a placental or decidual source. Higher circulating IGFBP1 levels were associated with greater insulin sensitivity (lesser insulin resistance) at ~26 weeks gestation in the same cohort and in two additional pregnancy cohorts. In addition, low circulating IGFBP1 levels in early pregnancy predicted subsequent GDM diagnosis in two cohorts of pregnant women. These results implicate IGFBP1 in the glycemic physiology of pregnancy and suggest a role for placental IGFBP1 deficiency in GDM pathogenesis.

Indexed as

Diabetes, GestationalInsulin-Like Growth Factor Binding Protein 1Insulin ResistancePlacentaAdultCohort StudiesFemaleGene Expression ProfilingHumansPregnancyIGFBP1 protein, humanInsulin-Like Growth Factor Binding Protein 1

Identifiers

PMID38627562
PMCPMC11186792
OpenAlexW4394832188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.